Developing a SARS-CoV-2 Vaccine at Warp Speed

Viewpoint discusses the 5 leading COVID-19 vaccine candidates—2 messenger RNA vaccines, 1 recombinant VSV vector product, and 2 replication-defective adenovirus vector vaccines—and emphasises need to demonstrate safety as well as efficacy to facilitate broad uptake by the public.


Journal of the American Medical Association